Naphthoic Acid

Naphthoic Acid

SCHEMBL29513330

O=C(O)c1cccc2ccccc12.O=C(O)c1cccc2ccccc12.[Co]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.95
NR4A2 P43354 1/20 0.95
NR4A3 Q92570 1/20 0.95
CDC25B P30305 2/20 0.74
WDR5 P61964 1/20 0.61
PTPN1 P18031 2/20 0.60
LDHA P00338 1/20 0.59
MMP3 P08254 1/20 0.59
HDAC8 Q9BY41 1/20 0.59
PLK1 P53350 1/20 0.57
ALDH1A1 P00352 4/20 0.56
ALOX15 P16050 1/20 0.56
GFER P55789 1/20 0.54
KDM4E B2RXH2 1/20 0.53
HSD17B10 Q99714 1/20 0.52
MAPT P10636 2/20 0.51
HPGD P15428 2/20 0.51
HTT P42858 2/20 0.51
HSP90AA1 P07900 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthoic Acid SCHEMBL56567 1.00 NR4A1 (0.95) NR4A1NR4A2NR4A3CDC25BWDR5
Naphthoic Acid SCHEMBL8575592 1.00 NR4A1 (0.95) NR4A1NR4A2NR4A3CDC25BWDR5
Naphthoic Acid SCHEMBL28163350 1.00 NR4A1 (0.95) NR4A1NR4A2NR4A3CDC25BWDR5
Naphthoic Acid SCHEMBL27990810 0.98 NR4A1 (0.91) NR4A1NR4A2NR4A3CDC25BWDR5
Naphthoic Acid SCHEMBL27517856 0.98 NR4A1 (0.91) NR4A1NR4A2NR4A3CDC25BWDR5
Naphthoic Acid SCHEMBL27475915 0.98 NR4A1 (0.91) NR4A1NR4A2NR4A3CDC25BWDR5
Naphthoic Acid SCHEMBL28248752 0.98 NR4A1 (0.91) NR4A1NR4A2NR4A3CDC25BWDR5
Naphthoic Acid SCHEMBL28133789 0.98 NR4A1 (0.91) NR4A1NR4A2NR4A3CDC25BWDR5
Naphthoic Acid SCHEMBL6550886 0.98 NR4A1 (0.91) NR4A1NR4A2NR4A3CDC25BWDR5
Naphthoic Acid SCHEMBL27539554 0.98 NR4A1 (0.91) NR4A1NR4A2NR4A3CDC25BWDR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119752273-A Color steel tile retreading coating and preparation method thereof 广东珠江化工涂料有限公司 2025-04-04 CN claimed
CN-118879113-B Double-component spray-coating unsaturated polyester resin putty and preparation method thereof 英德市荣昌化工实业有限公司 2025-03-14 CN claimed
CN-118879113-A Double-component spray-coating unsaturated polyester resin putty and preparation method thereof 英德市荣昌化工实业有限公司 2024-11-01 CN claimed
CN-116023616-B Polyurethane foam containing interpenetrating network structure and preparation method and application thereof 上海优玥新材料科技有限公司 2024-10-29 CN claimed
CN-118390350-A Construction method for repairing permeable concrete cracks 中冶建工集团有限公司 2024-07-26 CN claimed
CN-117963884-A High-capacity asphalt-based hard carbon composite material and preparation method thereof 青岛新泰和纳米科技有限公司 2024-05-03 CN claimed
CN-112310635-B High-strength high-wave-permeability small-wind-resistance radome and production process thereof 东莞东石新材料开发有限公司 2024-03-12 CN claimed
CN-115178097-B PVDF microporous filter membrane and preparation process thereof 无锡零界净化设备股份有限公司 2024-02-23 CN claimed
CN-114141961-B Regulation layer, preparation method and photoelectric device 深圳市华星光电半导体显示技术有限公司 2023-10-17 CN claimed
CN-116726734-A Corrosion-resistant microporous filter membrane and preparation method thereof 爱西默科技(上海)有限公司 2023-09-12 CN claimed
CN-116023616-A Polyurethane foam containing interpenetrating network structure and preparation method and application thereof 上海优玥新材料科技有限公司 2023-04-28 CN claimed
US-20250223272-A1 COOLING PROCESSES TO PRODUCE ACFC WITH INCREASED CRYSTAL SIZE WITH PURGE EASTMAN CHEMICAL COMPANY (US) 2025-07-10 US disclosed
EP-4025567-B1 EFFICIENT PROCESS FOR PRODUCING 5-(ALKOXYCARBONYL)-FURAN-2-CARBOXYLIC ACIDS EASTMAN CHEM CO (US) 2025-04-23 EP disclosed
CN-119752273-A Color steel tile retreading coating and preparation method thereof 广东珠江化工涂料有限公司 2025-04-04 CN disclosed
CN-119613692-A Polyesterimine resin and preparation method and application thereof 欧邦科技(苏州)有限公司 2025-03-14 CN disclosed
US-20220363654-A1 EFFICIENT PROCESS FOR PRODUCING 5-(ALKOXYCARBONYL)-FURAN-2-CARBOXYLIC ACIDS EASTMAN CHEMICAL COMPANY (US) 2022-11-17 US disclosed
US-11440895-B2 Oxidation process to produce 5-(alkoxycarbonyl)furan-2-carboxylic acids (ACFC) EASTMAN CHEMICAL COMPANY (US) 2022-09-13 US disclosed
EP-4025567-A1 EFFICIENT PROCESS FOR PRODUCING 5-(ALKOXYCARBONYL)-FURAN-2-CARBOXYLIC ACIDS Eastman Chemical Company (US) 2022-07-13 EP disclosed
EP-3321260-B1 COMPOSITION OBTAINED BY PURIFYING CRUDE FURAN 2,5-DICARBOXYLIC ACID BY HYDROGENATION EASTMAN CHEM CO (US) 2022-07-13 EP disclosed
US-11236199-B2 Oxidation process to produce 5-(alkoxycarbonyl)furan-2-carboxylic acids (ACFC) EASTMAN CHEMICAL COMPANY (US) 2022-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363654-A1 EFFICIENT PROCESS FOR PRODUCING 5-(ALKOXYCARBONYL)-FURAN-2-CARBOXYLIC ACIDS CA5B, ACACA, CPNE4 NR4A1 2884/4885NR4A2 1891/4885NR4A3 2656/4885
US-20250223272-A1 COOLING PROCESSES TO PRODUCE ACFC WITH INCREASED CRYSTAL SIZE WITH PURGE ACACA, ADCY10, MCCC2 NR4A1 3950/4885NR4A2 4236/4885NR4A3 4574/4885
US-11236199-B2 Oxidation process to produce 5-(alkoxycarbonyl)furan-2-carboxylic acids (ACFC) MCCC2, ACSL5, ACACB NR4A1 3249/4885NR4A2 2784/4885NR4A3 2998/4885
US-11440895-B2 Oxidation process to produce 5-(alkoxycarbonyl)furan-2-carboxylic acids (ACFC) MCCC2, ACSL5, ACACB NR4A1 3249/4885NR4A2 2784/4885NR4A3 2998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.